StreetInsider.com News Articles

Jefferies Starts Concentra Group Holdings Parent Inc (CON) at Buy

Fri, 16 Oct 2026 04:26:57 -0400

Jefferies analyst Jack Slevin initiates coverage on Concentra Group Holdings Parent Inc (NYSE: CON) with a Buy rating and a price target of $47.00.

The analyst comments: “CON is a high-quality compounder (+HSD% Core EBITDA growth) with differentiated ROIC (11-13% v. peer avg at 6-9%), a structurally advantaged payor mix that improves its risk profile, and a dominant position in the Occupational Health industry. Shares have re-rated amid deleveraging, but we believe recent volume strength should be durable & that it deserves a premium multiple v. peers (PT at ~14x vs. peers at ~11x EV/EBITDA).

CON Is the Dominant Player in the

Jefferies Starts Concentra Group Holdings Parent Inc (CON) at Buy

Fri, 16 Oct 2026 04:26:57 -0400

Jefferies analyst Jack Slevin initiates coverage on Concentra Group Holdings Parent Inc (NYSE: CON) with a Buy rating and a price target of $47.00.

CON Is the Dominant Player in the

Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026

Thu, 08 Oct 2026 16:30:00 -0400

DALLAS--(BUSINESS WIRE)-- Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its third quarter ended September 30, 2026, on Thursday, November 5, 2026, after the market closes.

Concentra will host a conference call regarding its financial results on Friday, November 6, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the

Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026

Thu, 08 Oct 2026 16:30:00 -0400

Concentra opens first Volusia County location in Daytona Beach

Mon, 14 Sep 2026 09:00:40 -0400

Concentra (NYSE: CON) has opened a new medical center in Daytona Beach, Florida, marking the company's first location in Volusia County, according to a press release from the occupational health services provider.

The center is located at 2200 W. International Speedway, Suite 2, near Interstate 95 and Daytona International Speedway. It is positioned to serve employers in Daytona Beach, Ormond Beach, Port Orange, Holly Hill, South Daytona, and surrounding communities.

The facility offers occupational health services including work injury care, physical therapy, Department of Transportation physical examinations, pre-placement physicals, medical surveillance, respirator fit testing, and drug and alcohol screening. Concentra Telemed is

Concentra Expands Florida Footprint with New Daytona Beach Medical Center

Mon, 14 Sep 2026 09:00:00 -0400

New center accelerates access to occupational health services for employers and employees across Volusia County

DAYTONA BEACH, Fla.--(BUSINESS WIRE)-- Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced the opening of its newest Florida medical center and first location in Volusia County. The Daytona Beach medical center expands access to occupational health services for employers and employees throughout the Greater Daytona region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914303926/en/

Daytona Beach sits at the

Concentra Expands Florida Footprint with New Daytona Beach Medical Center

Mon, 14 Sep 2026 09:00:00 -0400

New center accelerates access to occupational health services for employers and employees across Volusia County

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914303926/en/

Daytona Beach sits at the

Concentra Group Holdings Parent Inc (CON) PT Raised to $43 at JPMorgan

Thu, 10 Sep 2026 08:36:59 -0400

JPMorgan analyst Benjamin Rossi raised the price target on Concentra Group Holdings Parent Inc (NYSE: CON) to $43.00 (from $34.00) while maintaining a Overweight rating.

Form 8-K Concentra Group Holdings For: Sep 04

Tue, 08 Sep 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260908/27037272.html

Concentra names Tanner Newton as next CFO, effective Nov. 2026

Tue, 08 Sep 2026 09:00:22 -0400

Concentra (NYSE: CON) announced that Tanner Newton, currently senior vice president of strategy and finance, will become executive vice president and chief financial officer effective Nov. 1, 2026.

Newton's appointment is part of a multiyear leadership succession plan previously announced by Concentra and unanimously approved by its board of directors. He will continue to report to Matt DiCanio, who currently serves as president and CFO and will transition to president and chief executive officer on the same date.

In his new role, Newton will oversee accounting, financial reporting, financial planning and analysis, treasury, tax, capital markets, corporate development, and investor relations.

Newton joined

Concentra Appoints Tanner Newton Chief Financial Officer

Tue, 08 Sep 2026 09:00:00 -0400

Experienced Concentra leader brings deep knowledge of the company’s strategy, financial operations and investor community

DALLAS--(BUSINESS WIRE)-- Concentra® (NYSE: CON), the nation’s leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908629564/en/

Tanner Newton

Newton will continue to report to Matt DiCanio, Concentra’s president and chief financial officer,

Concentra Appoints Tanner Newton Chief Financial Officer

Tue, 08 Sep 2026 09:00:00 -0400

Experienced Concentra leader brings deep knowledge of the company’s strategy, financial operations and investor community

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908629564/en/

Tanner Newton

Newton will continue to report to Matt DiCanio, Concentra’s president and chief financial officer,

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Tue, 01 Sep 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260901/27013261.html

Form 4/A Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 01 Sep 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260901/27012899.html

Form 8-K Concentra Group Holdings For: Aug 21

Thu, 27 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260827/26990792.html

Form 8-K Concentra Group Holdings For: Aug 21

Thu, 27 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260827/26990792.html

Form 4 Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 25 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26975589.html

Form 4 Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 25 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26975589.html

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Mon, 24 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260824/26968507.html

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Mon, 24 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260824/26968507.html

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

Dr. Rosenthal returns to Concentra, where she previously held physician leadership roles including area medical director. Most recently, she served as chief medical officer at Zenith Insurance Company for more than 16 years. She also currently serves as the 2026 president of the American College of Occupational and Environmental Medicine.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Tue, 18 Aug 2026 09:00:00 -0400

DALLAS--(BUSINESS WIRE)-- Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer, effective Jan. 1, 2027. Returning to the organization where she previously served in physician leadership roles, including area medical director, Dr. Rosenthal will lead Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation as employers increasingly seek integrated workforce health solutions. She succeeds longtime chief medical officer, Dr. John Anderson, who previously